Cav3.1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Cav3.1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cav3.1 is the α1G subunit of voltage-gated calcium channels, forming the pore of the T-type (low-voltage activated) calcium channel. It is encoded by the CACNA1G gene.
| Property | Value |
|---|---|
| Protein Name | Cav3.1 (T-type calcium channel subunit α1G) |
| Gene | CACNA1G |
| UniProt ID | O43497 |
| PDB Structure | 6JPA (channel complex) |
| Molecular Weight | ~240 kDa |
| Subcellular Localization | Dendrites, cell body, proximal axon |
| Protein Family | Voltage-gated calcium channel α1 family (CaV3) |
Cav3.1 has the typical structure of T-type calcium channel α1 subunits:
Key structural differences from high-voltage activated channels:
Cav3.1 (T-type) channels are crucial for:
| Approach | Compound | Status | Notes |
|---|---|---|---|
| Direct blocker | Ethosuximide | Approved | First-line for absence seizures |
| Broad blocker | Zonisamide | Approved | Blocks T-type and Na+ channels |
| State-dependent | Phenobarbital | Approved | Barbiturates inhibit T-type |
| Selective | Z944 | Clinical trials | Advanced T-type blocker |
Cav3.1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cav3.1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Wu J, et al. Nature 2020;585:e5. PMID:33268865
[2] Huguenard JR, et al. Annu Rev Physiol 2002;64:159-187. PMID:11830674
[3] Chen Y, et al. Ann Neurol 2013;74:423-431. PMID:23780923
[4] Coutelier M, et al. Brain 2015;138:3163-3177. PMID:26637561
[5] Hwang J, et al. Brain 2019;142:2086-2101. PMID:31219789
[6] Cain SM, et al. Channels 2017;11:305-323. PMID:28473962
[7] Powell KL, et al. Brain 2014;137:2130-2140. PMID:24736303
[8] Kim D, et al. J Neurosci 2001;21:3064-3072. PMID:11306631